# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 12, "Diabetologia", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasJournal> \"Diabetologia\"."
1, PublicationYear, 15, 19, "2014", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasPublicationYear> \"2014\"."
139, Title, 113, 310, "HARMONY 4 : randomised clinical trial comparing once - weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea .", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasTitle> \"HARMONY 4 : randomised clinical trial comparing once - weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea .\"."
2, Randomized, 125, 135, "randomised", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
3, Frequency, 161, 174, "once - weekly", "", 
79658, Albiglutide, 175, 186, "albiglutide", "", "<http://ctro/data#Medication_67621> <http://ctro/data#hasDrug> <http://ctro/data#Albiglutide>."
13, InsulinGlargine, 191, 207, "insulin glargine", "", 
31, Precondition, 211, 308, "patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea", "", "<http://ctro/data#Population_67571> <http://ctro/data#hasPrecondition> \"patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea\"."
22, Type2Diabetes, 225, 240, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
25, Metformin, 270, 279, "metformin", "", 
28, Sulfonylureas, 296, 308, "sulfonylurea", "", 
34, Author, 311, 322, "Weissman PN", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Weissman PN\"."
35, Author, 331, 338, "Carr MC", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Carr MC\"."
36, Author, 341, 345, "Ye J", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Ye J\"."
37, Author, 348, 357, "Cirkel DT", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Cirkel DT\"."
38, Author, 360, 369, "Stewart M", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Stewart M\"."
39, Author, 372, 379, "Perry C", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Perry C\"."
40, Author, 382, 391, "Pratley R", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasAuthor> \"Pratley R\"."
41, USA, 494, 497, "USA", "", 
47, ObjectiveDescription, 578, 716, "compare the efficacy and safety of once - weekly albiglutide with once - daily insulin glargine ( A21Gly , B31Arg , B32Arg human insulin )", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasObjectiveDescription> \"compare the efficacy and safety of once - weekly albiglutide with once - daily insulin glargine ( A21Gly , B31Arg , B32Arg human insulin )\"."
42, Frequency, 613, 626, "once - weekly", "", 
79660, Albiglutide, 627, 638, "albiglutide", "", 
43, Frequency, 644, 656, "once - daily", "", 
14, InsulinGlargine, 657, 673, "insulin glargine", "", 
46, FixedCombDrug, 676, 714, "A21Gly , B31Arg , B32Arg human insulin", "", 
48, ObjectiveDescription, 717, 817, "in patients with type 2 diabetes inadequately controlled on metformin with or without sulfonylurea .", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasObjectiveDescription> \"in patients with type 2 diabetes inadequately controlled on metformin with or without sulfonylurea .\"."
32, Precondition, 720, 815, "patients with type 2 diabetes inadequately controlled on metformin with or without sulfonylurea", "", 
23, Type2Diabetes, 734, 749, "type 2 diabetes", "", 
153, Precondition, 750, 815, "inadequately controlled on metformin with or without sulfonylurea", "", 
26, Metformin, 777, 786, "metformin", "", 
29, Sulfonylureas, 803, 815, "sulfonylurea", "", 
49, Randomized, 839, 849, "randomised", "", 
50, OpenLabel, 852, 864, "open - label", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
51, Multicenter, 867, 878, "multicentre", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
52, Parallel, 895, 911, "parallel - group", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
53, CTDesign, 914, 931, "non - inferiority", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
54, NumberPatientsCT, 968, 971, "779", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasNumberPatientsCT> \"779\"."
77564, Precondition, 1072, 1140, "Patients aged ≥ 18 years with type 2 diabetes treated with metformin", "", "<http://ctro/data#Population_67571> <http://ctro/data#hasPrecondition> \"Patients aged ≥ 18 years with type 2 diabetes treated with metformin\"."
55, MinAge, 1088, 1090, "18", "", "<http://ctro/data#Population_67571> <http://ctro/data#hasMinAge> \"18\"."
165, Year, 1091, 1096, "years", "", 
24, Type2Diabetes, 1102, 1117, "type 2 diabetes", "", 
27, Metformin, 1131, 1140, "metformin", "", 
30, Sulfonylureas, 1145, 1157, "sulfonylurea", "", 
183, Duration, 1173, 1181, "3 months", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasCTduration> \"3 months\"."
169, TimePoint, 1189, 1197, "baseline", "", 
56, HbA1c, 1198, 1203, "HbA1c", "", 
57, Percentage, 1219, 1220, "%", "", 
79683, Millimoles_per_mole, 1239, 1249, "mmol / mol", "", 
60, Randomized, 1257, 1265, "randomly", "", 
61, AllocationRatio, 1277, 1282, "2 : 1", "", "<http://ctro/data#AllocationRatio_67559> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio>. <http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_67559>."
172, Randomized, 1312, 1325, "randomisation", "", 
79659, Albiglutide, 1375, 1386, "albiglutide", "", 
62, DoseValue, 1389, 1391, "30", "", "<http://ctro/data#Medication_67621> <http://ctro/data#hasDoseValue> \"30\"."
64, mg, 1392, 1394, "mg", "", "<http://ctro/data#Medication_67621> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
44, Frequency, 1395, 1406, "once a week", "", "<http://ctro/data#Intervention_67597> <http://ctro/data#hasFrequency> \"once a week\"."
66, NumberPatientsArm, 1415, 1418, "504", "", "<http://ctro/data#Arm_67579> <http://ctro/data#hasNumberPatientsArm> \"504\"."
15, InsulinGlargine, 1424, 1440, "insulin glargine", "", "<http://ctro/data#Medication_67628> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
63, DoseValue, 1443, 1445, "10", "", "<http://ctro/data#Medication_67628> <http://ctro/data#hasDoseValue> \"10\"."
179, Int_Unit, 1446, 1447, "U", "", "<http://ctro/data#Medication_67628> <http://ctro/data#hasDoseUnit> <http://ctro/data#Int_Unit>."
45, Frequency, 1448, 1458, "once a day", "", "<http://ctro/data#Intervention_67603> <http://ctro/data#hasFrequency> \"once a day\"."
67, NumberPatientsArm, 1467, 1470, "241", "", "<http://ctro/data#Arm_67588> <http://ctro/data#hasNumberPatientsArm> \"241\"."
187, OpenLabel, 1536, 1546, "not masked", "", 
68, DoseDescription, 1573, 1652, "Doses of each medication were adjusted on the basis of the glycaemic response .", "", "<http://ctro/data#Medication_67621> <http://ctro/data#hasDoseDescription> \"Doses of each medication were adjusted on the basis of the glycaemic response .\". <http://ctro/data#Medication_67628> <http://ctro/data#hasDoseDescription> \"Doses of each medication were adjusted on the basis of the glycaemic response .\"."
70, TimePoint, 1690, 1698, "baseline", "", 
69, HbA1c, 1702, 1707, "HbA1c", "", 
71, TimePoint, 1711, 1718, "week 52", "", 
79661, Albiglutide, 1738, 1749, "albiglutide", "", 
75, HbA1c, 1758, 1763, "HbA1c", "", "<http://ctro/data#Endpoint_67668> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
77, BaseLineValue, 1778, 1784, "8 . 28", "", "<http://ctro/data#Outcome_67673> <http://ctro/data#hasBaselineValue> \"8 . 28\"."
79, SdDevBL, 1789, 1795, "0 . 90", "", "<http://ctro/data#Outcome_67673> <http://ctro/data#hasSdDevBL> \"0 . 90\"."
81, Percentage, 1796, 1797, "%", "", "<http://ctro/data#Endpoint_67668> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
78, BaseLineValue, 1800, 1806, "67 . 0", "", 
80, SdDevBL, 1811, 1816, "9 . 8", "", 
79685, Millimoles_per_mole, 1817, 1827, "mmol / mol", "", 
203, Mean, 1832, 1836, "mean", "", "<http://ctro/data#Mean_67670> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_67668> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_67670>."
73, TimePoint, 1849, 1857, "baseline", "", 
86, ResultMeasuredValue, 1861, 1867, "7 . 62", "", "<http://ctro/data#Outcome_67673> <http://ctro/data#hasResultMeasuredValue> \"7 . 62\"."
88, SdDevResValue, 1872, 1878, "1 . 12", "", "<http://ctro/data#Outcome_67673> <http://ctro/data#hasSdDevResValue> \"1 . 12\"."
82, Percentage, 1879, 1880, "%", "", 
87, ResultMeasuredValue, 1883, 1889, "59 . 8", "", 
89, SdDevResValue, 1894, 1900, "12 . 2", "", 
79694, Millimoles_per_mole, 1901, 1911, "mmol / mol", "", 
72, TimePoint, 1917, 1924, "week 52", "", "<http://ctro/data#Outcome_67673> <http://ctro/data#hasTimePoint> \"week 52\"."
16, InsulinGlargine, 1963, 1979, "insulin glargine", "", 
93, BaseLineValue, 1988, 1994, "8 . 36", "", "<http://ctro/data#Outcome_67700> <http://ctro/data#hasBaselineValue> \"8 . 36\"."
95, SdDevBL, 1999, 2005, "0 . 95", "", "<http://ctro/data#Outcome_67700> <http://ctro/data#hasSdDevBL> \"0 . 95\"."
97, Percentage, 2006, 2007, "%", "", 
92, ResultMeasuredValue, 2011, 2017, "7 . 55", "", "<http://ctro/data#Outcome_67700> <http://ctro/data#hasResultMeasuredValue> \"7 . 55\"."
90, SdDevResValue, 2022, 2028, "1 . 04", "", "<http://ctro/data#Outcome_67700> <http://ctro/data#hasSdDevResValue> \"1 . 04\"."
98, Percentage, 2029, 2030, "%", "", 
94, BaseLineValue, 2033, 2039, "67 . 9", "", 
96, SdDevBL, 2044, 2050, "10 . 4", "", 
91, ResultMeasuredValue, 2054, 2060, "59 . 0", "", 
99, SdDevResValue, 2065, 2071, "11 . 4", "", 
79688, Millimoles_per_mole, 2072, 2082, "mmol / mol", "", 
101, DiffGroupAbsValue, 2134, 2140, "0 . 11", "", "<http://ctro/data#DiffBetweenGroups_67727> <http://ctro/data#hasDiffGroupAbsValue> \"0 . 11\"."
102, Percentage, 2141, 2142, "%", "", 
105, ConfIntervalDiff, 2145, 2174, "95 % CI - 0 . 04 % , 0 . 27 %", "", "<http://ctro/data#DiffBetweenGroups_67727> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 0 . 04 % , 0 . 27 %\"."
103, Percentage, 2162, 2163, "%", "", 
104, Percentage, 2173, 2174, "%", "", 
108, DiffGroupAbsValue, 2179, 2184, "1 . 2", "", 
79690, Millimoles_per_mole, 2185, 2195, "mmol / mol", "", 
106, ConfIntervalDiff, 2198, 2232, "95 % CI - 0 . 4 , 3 . 0 mmol / mol", "", 
79697, Millimoles_per_mole, 2222, 2232, "mmol / mol", "", 
79662, Albiglutide, 2268, 2279, "albiglutide", "", 
17, InsulinGlargine, 2283, 2299, "insulin glargine", "", 
228, Percentage, 2363, 2364, "%", "", 
79692, Millimoles_per_mole, 2373, 2383, "mmol / mol", "", 
110, PvalueDiff, 2386, 2400, "p  =  0 . 0086", "", "<http://ctro/data#DiffBetweenGroups_67727> <http://ctro/data#hasPvalueDiff> \"p  =  0 . 0086\"."
112, BodyWeight, 2405, 2416, "Body weight", "", "<http://ctro/data#Endpoint_67736> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
113, ObservedResult, 2417, 2426, "increased", "", "<http://ctro/data#Outcome_67768> <http://ctro/data#hasObservedResult> \"increased\"."
18, InsulinGlargine, 2434, 2450, "insulin glargine", "", 
114, ObservedResult, 2461, 2470, "decreased", "", "<http://ctro/data#Outcome_67741> <http://ctro/data#hasObservedResult> \"decreased\"."
79663, Albiglutide, 2478, 2489, "albiglutide", "", 
236, Mean, 2505, 2509, "mean", "", "<http://ctro/data#Mean_67738> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_67736> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_67738>."
115, DiffGroupAbsValue, 2534, 2542, "- 2 . 61", "", "<http://ctro/data#DiffBetweenGroups_67795> <http://ctro/data#hasDiffGroupAbsValue> \"- 2 . 61\"."
116, Kg, 2543, 2545, "kg", "", "<http://ctro/data#Endpoint_67736> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
117, ConfIntervalDiff, 2548, 2575, "95 % CI - 3 . 20 , - 2 . 02", "", "<http://ctro/data#DiffBetweenGroups_67795> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 3 . 20 , - 2 . 02\"."
118, PvalueDiff, 2578, 2592, "p  <  0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_67795> <http://ctro/data#hasPvalueDiff> \"p  <  0 . 0001\"."
119, SymptomaticHypoglycemia, 2608, 2633, "symptomatic hypoglycaemia", "", "<http://ctro/data#Endpoint_67804> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia>."
19, InsulinGlargine, 2685, 2701, "insulin glargine", "", 
79664, Albiglutide, 2720, 2731, "albiglutide", "", 
120, PercentageAffected, 2740, 2746, "27 . 4", "", "<http://ctro/data#Outcome_67836> <http://ctro/data#hasPercentageAffected> \"27 . 4\"."
121, PercentageAffected, 2752, 2758, "17 . 5", "", "<http://ctro/data#Outcome_67809> <http://ctro/data#hasPercentageAffected> \"17 . 5\"."
122, PvalueDiff, 2763, 2777, "p  =  0 . 0377", "", "<http://ctro/data#Outcome_67809> <http://ctro/data#hasPercentageAffected> \"17 . 5\"."
79665, Albiglutide, 2813, 2824, "Albiglutide", "", 
125, ConclusionComment, 2813, 2943, "Albiglutide was non - inferior to insulin glargine at reducing HbA1c at week 52 , with modest weight loss and less hypoglycaemia .", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasConclusionComment> \"Albiglutide was non - inferior to insulin glargine at reducing HbA1c at week 52 , with modest weight loss and less hypoglycaemia .\"."
20, InsulinGlargine, 2847, 2863, "insulin glargine", "", 
76, HbA1c, 2876, 2881, "HbA1c", "", 
74, TimePoint, 2885, 2892, "week 52", "", 
254, WeightReduction, 2907, 2918, "weight loss", "", 
124, Hypoglycemia, 2928, 2941, "hypoglycaemia", "", 
126, ConclusionComment, 2944, 2976, "Both drugs were well tolerated .", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasConclusionComment> \"Both drugs were well tolerated .\"."
79666, Albiglutide, 2977, 2988, "Albiglutide", "", 
127, ConclusionComment, 2977, 3070, "Albiglutide may be considered an alternative to insulin glargine in this patient population .", "", "<http://ctro/data#ClinicalTrial_67555> <http://ctro/data#hasConclusionComment> \"Albiglutide may be considered an alternative to insulin glargine in this patient population .\"."
21, InsulinGlargine, 3025, 3041, "insulin glargine", "", 
106275, PharmacySponsored, 3149, 3204, "This study was planned and conducted by GlaxoSmithKline", "", "<http://ctro/data#EvidenceQuality_91578> <http://ctro/data#isPharmacySponsored> \"This study was planned and conducted by GlaxoSmithKline\"."
128, PMID, 3256, 3264, "25208756", "", "<http://ctro/data#Publication_67548> <http://ctro/data#hasPMID> \"25208756\"."
